The bradykinin-degrading aminopeptidase P is increased in women taking the oral contraceptive pill
@article{Corte2008TheBA, title={The bradykinin-degrading aminopeptidase P is increased in women taking the oral contraceptive pill}, author={Amy L Cilia La Corte and A. Carter and A. Turner and P. J. Grant and N. Hooper}, journal={Journal of the Renin-Angiotensin-Aldosterone System}, year={2008}, volume={9}, pages={221 - 225} }
Introduction. The renin-angiotensin and kininogen-kinin hormonal systems are critically involved in regulating blood pressure and are candidates in contributing to oral contraceptive pill (OCP)-induced hypertension.Angiotensin-converting enzyme (ACE) and aminopeptidase P (AP-P) are key enzymes in these systems and are both involved in the degradation of the vasodilator bradykinin. Methods. Circulating ACE and AP-P levels were measured by activity assay using selective fluorogenic peptide… CONTINUE READING
15 Citations
A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor‐induced angioedema
- Biology, Medicine
- Human mutation
- 2011
- 56
Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema
- Medicine
- Pharmacogenetics and genomics
- 2010
- 68
Associations between oral contraceptive use and risks of hypertension and prehypertension in a cross-sectional study of Korean women
- Medicine
- BMC Women's Health
- 2013
- 16
- PDF
Pharmacoinformatics study of Piperolactam A from Piper betle root as new lead for non steroidal anti fertility drug development
- Chemistry, Computer Science
- Comput. Biol. Chem.
- 2017
- 16
Elevated Aminopeptidase P Attenuates Cerebral Arterial Responses to Bradykinin in Fawn-Hooded Hypertensive Rats
- Medicine
- PloS one
- 2015
- 2
- PDF
Association between duration of oral contraceptive use and risk of hypertension: A meta‐analysis
- Medicine
- Journal of clinical hypertension
- 2017
- 20
Benefits of progestin contraception in non‐allergic angioedema
- Medicine
- Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
- 2013
- 54
References
SHOWING 1-10 OF 23 REFERENCES
Inhibition of both aminopeptidase P and angiotensin-converting enzyme prevents bradykinin degradation in the rat coronary circulation.
- Chemistry, Medicine
- Journal of cardiovascular pharmacology
- 1997
- 38
Inhibition of aminopeptidase P potentiates wheal response to bradykinin in angiotensin-converting enzyme inhibitor-treated humans.
- Chemistry, Medicine
- The Journal of pharmacology and experimental therapeutics
- 2000
- 45
- PDF
Dipeptidyl Peptidase IV Activity in Patients With ACE-Inhibitor-Associated Angioedema
- Medicine
- Hypertension
- 2002
- 100
Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P.
- Medicine
- The Journal of allergy and clinical immunology
- 2008
- 97
Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma.
- Chemistry, Medicine
- American journal of physiology. Heart and circulatory physiology
- 2001
- 126
- PDF
Renal characteristics and effect of angiotensin suppression in oral contraceptive users.
- Medicine
- Hypertension
- 1999
- 63
- PDF
Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.
- Chemistry, Medicine
- The Biochemical journal
- 2004
- 441
- PDF
Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women.
- Medicine
- Circulation
- 1997
- 383
The angiotensin-converting enzyme gene family: genomics and pharmacology.
- Biology, Medicine
- Trends in pharmacological sciences
- 2002
- 333
Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women
- Medicine
- The Lancet
- 1995
- 203